300381.SZ
溢多利
SZSE · Healthcare · C 制造业 · CN
CNY 6.21
−1.27%Year over year
Reported trailing growth
- Revenue
- +1.5%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +66.9%
- Operating cash flow
- +1943.9%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -10.8%
- EBITDA
- -21.3%
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- +49.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026